With over 40% of American adults obese, the first truly effective weight-reduction therapies will be giant sellers. However, the harsh side effects and the cost may crimp growth of these weight-loss drugs, explains Breakingviews columnist Rob Cyran.
Keep up with the latest news from around the world: https://www.reuters.com/
#BVPredicts #breakingviews #weightloss #weightlossdrugs #obesity #obesitymedicine #News #Reuters #newsfeed
Subscribe: http://smarturl.it/reuterssubscribe
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
Keep up with the latest news from around the world: https://www.reuters.com/
#BVPredicts #breakingviews #weightloss #weightlossdrugs #obesity #obesitymedicine #News #Reuters #newsfeed
Subscribe: http://smarturl.it/reuterssubscribe
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: https://www.reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en
Sign in or sign up to post comments.
Be the first to comment